Workshop - Washington, DC, United States
Stem cells hold tremendous potential to advance health and medicine. Through replacement of damaged cells and organs or supporting intrinsic repair, stem cells hold the potential to be used in the treatment of debilitating diseases and conditions such as Parkinson’s disease, diabetes, and spinal cord injury. Currently, however, the evidence base to support the medical use of stem cells is still limited, with few clinical applications shown to be safe and effective. Despite the preliminary nature of clinical evidence, consumer demand for treatments using stem cells has risen, fueled by direct-to-consumer advertising of stem cell-based treatments. Clinics have been established throughout the world, both in newly industrialized nations as well as developed countries. This workshop will take a critical look at the current environment in which patients are receiving unregulated stem cells treatments. Speakers will examine the stem cell treatments that are being offered, the potential benefits and risks to individual health, and the evidence base needed to substantiate the clinical application of stem cell technologies. The workshop will also explore whether to consider international standards and criteria to govern unregulated clinical stem cell applications.
Organization: National Academy of Sciences
(Courtesy of National Academy of Sciences, via en.wikipedia.org)
Mon, Nov 18, 2013 - Mon, Nov 18, 2013
National Academy of Sciences
2101 Constitutional Avenue, Room 125, Washington, DC, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
